10-K Decoder · All companies

Rigel Pharmaceuticals, Inc.

RIGL · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$294M$179M+64.1%
Operating income$125M$24.2M+419%
Net income$367M$17.5M+2,000%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 5, 2026

$Q3 2026Year earlierChange
Revenue$80.9M$69.5M+16.4%
Operating income$17.1M$28.4M−39.8%
Net income$13.2M$27.9M−52.7%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Rigel Pharmaceuticals's revenue in FY2025?
$294M in FY2025 (Fiscal year ended Dec 31, 2025), +64.1% vs $179M a year earlier, per its 10-K filed Mar 2026.
Was Rigel Pharmaceuticals profitable in FY2025?
Yes: net income was $367M and operating income $125M in FY2025.
What was Rigel Pharmaceuticals's revenue in Q3 2026?
$80.9M (+16.4% vs a year earlier), per its Form 10-Q filed Nov 5, 2026.